Keyword Analysis & Research: daiichi sankyo
Keyword Research: People who searched daiichi sankyo also searched
Search Results related to daiichi sankyo on Search Engine
-
Daiichi Sankyo
https://www.daiichisankyo.com/
WebApr 11, 2024 · January 30, 2023. Daiichi Sankyo has been certified as a “DX Certified Operator” by the Ministry of Economy, Trade and Industry - Daiichi Sankyo. September 06, 2022. Daiichi Sankyo Company, Limited won the “Pharma Company of the Year” award at the first “Informa Pharma Intelligence Awards” in Japan.
DA: 61 PA: 40 MOZ Rank: 9
-
Passion for innovation. Compassion for patients. - Daiichi Sankyo …
https://daiichisankyo.us/
WebCorporate Video. For people affected by cancer, Daiichi Sankyo turns hope into possibility. Possibility into reality. Our collective craft is medicine. We’re transforming how cancer and other disease are treated. More than 120 year of heritage inspires us …
DA: 89 PA: 14 MOZ Rank: 87
-
Daiichi Sankyo - Wikipedia
https://en.wikipedia.org/wiki/Daiichi_Sankyo
WebDaiichi Sankyo Company, Limited ( Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. [3] . The company owns the American pharmaceutical company American Regent.
DA: 20 PA: 51 MOZ Rank: 57
-
About Us - Daiichi Sankyo
https://www.daiichisankyo.com/about_us/
WebMar 31, 2023 · Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
DA: 2 PA: 13 MOZ Rank: 59
-
Careers - Daiichi Sankyo
https://www.daiichisankyo.com/careers/
WebDaiichi Sankyo is an innovative global healthcare company based in Japan underpinned by its Purpose: “To contribute to the enrichment of quality of life around the world”.
DA: 78 PA: 74 MOZ Rank: 83
-
Company Profile - Daiichi-Sankyo US
https://daiichisankyo.us/en/company-profile
WebCorporate Information. In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel …
DA: 19 PA: 40 MOZ Rank: 83
-
Our Pipeline - Research & Development - Daiichi Sankyo
https://www.daiichisankyo.com/rd/pipeline/
WebJan 31, 2024 · Our Pipeline. We continuously develop and expand our robust pipeline to address patients' unmet medical needs. Our pursuit of new medicines is fueled by the scientific curiosity of our employees, a willingness to examine new ideas, and the pairing of existing information with novel concepts.
DA: 82 PA: 35 MOZ Rank: 38
-
Who We Are - Daiichi Sankyo US
https://daiichisankyo.us/en/about-us
WebAs the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability—learn more about who we are.
DA: 8 PA: 30 MOZ Rank: 26
-
Corporate Information - About Us - Daiichi Sankyo
https://www.daiichisankyo.com/about_us/corporate_info/
WebFounded on September 28, 2005 through the merger of Daiichi Pharmaceutical and Sankyo, Daiichi Sankyo delivers innovative products that enhance the lives of millions of people around the world. Daiichi Sankyo Co., Ltd. Head Office. 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo. 103-8426, Japan. Phone: +81-3-6225-1111. Access and map. Global …
DA: 62 PA: 75 MOZ Rank: 88
-
Daiichi Sankyo | LinkedIn
https://www.linkedin.com/company/daiichi-sankyo-co-ltd-
WebDaiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the...
DA: 53 PA: 36 MOZ Rank: 16
